Recent News
- Subcutaneous Trastuzumab Case: Achieving concentration of 250mg/mL at a syringeable viscosity of 18 cP.
- Worldwide patent granted for “High Concentration Protein Formulations with Reduced Viscosity”.
- Dr. Bhami Shenoy envisions a bright future for biologics in India.
- Purification of Trastuzumab using BRL’s crystallization technology.
- Purification of protein biologics by crystallization.